Treating muscle wasting with selective androgen receptor modulators
AssigneeUniversity of Tennessee Research Foundation
InventorsMitchell S. Steiner, Karen A. Veverka, James T. Dalton, Duane D. Miller
Life of this patent
Estimating the term…
Loading patent…
AssigneeUniversity of Tennessee Research Foundation
InventorsMitchell S. Steiner, Karen A. Veverka, James T. Dalton, Duane D. Miller
Estimating the term…
This invention provides: 1) a method of treating a subject suffering from a muscle wasting disorder; 2) a method of preventing a muscle wasting disorder in a subject; 3) a method of treating, preventing, suppressing, inhibiting or reducing muscle loss in a subject suffering from a muscle wasting disorder; 4) a method of treating, preventing, inhibiting, reducing or suppressing muscle wasting in a subject suffering from a muscle wasting disorder; and/or 5) a method of treating, preventing, inhibiting, reducing or suppressing muscle protein catabolism in a subject suffering from a muscle wasting disorder, by administering to the subject a selective androgen receptor modulator (SARM) and/or an analog, derivative, isomer, metabolite, pharmaceutically acceptable salt, pharmaceutical product, hydrate, N-oxide, prodrug, polymorph, impurity or crystal of said SARM compound, or any combination thereof.
A method of treating a subject suffering from a muscle wasting disorder, comprising the step of administering to said subject a selective androgen receptor modulator (SARM) compound represented by the structure of formula VI:
A method of treating or reducing muscle loss in a subject suffering from a muscle wasting disorder, comprising the step of administering to said subject a selective androgen receptor modulator (SARM) compound represented by the following structure of formula VI:
A method of treating or reducing muscle wasting in a subject suffering from a muscle wasting disorder, comprising the step of administering to said subject a selective androgen receptor modulator (SARM) compound represented by the structure of formula VI:
A method of treating or reducing muscle protein catabolism in a subject suffering from a muscle wasting disorder, comprising the step of administering to said subject a selective androgen receptor modulator (SARM) compound represented by the structure of formula VI:
Dependencies are inferred from the claim text.